MGC Pharmaceuticals to "keep chipping away" after first CannEpil delivery
London, UK --News Direct-- MGC Pharmaceuticals Ltd
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Thomas Warner from Proactive after the Europe-based pharmaceutical company announced the delivery of the first doses of its CannEpil® units to patients in the United Kingdom. Clements also discusses recent changes at boardroom level and looks ahead to what investors can expect from MGC during the next few months, saying that the company will "keep chipping away."
Contact Details
Proactive UK Ltd
+44 20 7989 0813
View original content to download multimedia: https://newsdirect.com/news/mgc-pharmaceuticals-to-keep-chipping-away-after-first-cannepil-delivery-115011927
This news release was distributed by News Direct Corp. (“News Direct”). News Direct is an industry-leading content and news distribution platform. This news release and all materials included within this news release, including, without limitation, all images, trademarks and logos, are protected by copyrights, trademarks, service marks, patents or other proprietary rights and laws. If you copy, broadcast, download, store (in any medium), transmit, show or play any multimedia content from this release in public, you must properly attribute said content to the company or organization from which the news release originated unless otherwise sourced. News Direct makes no warranties with respect to the accuracy or completeness of the information contained in this news release. News Direct hereby disclaims all warranties, whether express, implied, statutory or otherwise, in connection with this news release and the content within this news release.